(Q33349172)

26 July 2017

1 reference

title

Prophylactic platelet transfusions: which dose is the best dose? A review of the literature (English)

1 reference

26 July 2017

2

John Freedman

1 reference

26 July 2017

Alan T Tinmouth

1

1 reference

26 July 2017

1 July 2003

1 reference

Transfusion Medicine Reviews

26 July 2017

1 reference

26 July 2017

17

1 reference

26 July 2017

3

1 reference

26 July 2017

181-193

1 reference

THE RELATION OF BLOOD PLATELETS TO HEMORRHAGIC DISEASE

26 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

Blood collection and transfusion in the United States in 1997

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

Collection and transfusion of blood in the United States, 1982-1988.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

Prophylactic versus therapeutic platelet transfusion practices in hematology and/or oncology patients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

RESPONSE TO REPEATED PLATELET TRANSFUSION FROM THE SAME DONOR.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

Transfusions of Fresh Platelet Concentrates to Patients with Secondary Thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

Effect of platelet transfusion on hemorrhage in patients with acute leukemia: An autopsy study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

CAUSES OF DEATH IN ACUTE LEUKEMIA: A TEN-YEAR STUDY OF 414 PATIENTS FROM 1954-1963

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

The Prophylactic Treatment of Thrombocytopenic Leukemic Patients with Platelets: a Double Blind Study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

Platelet prophylaxis in acute non-lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

Indications for platelet transfusion in children with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

The quantitative relation between platelet count and hemorrhage in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

Conservative Management of Chemotherapeutic-Induced Thrombocytopenia in Women with Gynecologic Cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

Use of leucocyte-poor blood components and HLA-matched-platelet donors to prevent HLA alloimmunization

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

Transfusion of ABO-mismatched platelets leads to early platelet refractoriness

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

A prospective, randomized study of the use of platelet concentrates irradiated with ultraviolet-B light in patients with hematologic malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

Prevention of alloimmunization in patients with acute leukemia by use of white cell-reduced blood components--a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

The case against universal WBC reduction (and for the practice of evidence-based medicine).

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

Meta-analysis of randomized controlled trials of the efficacy of white cell reduction in preventing HLA-alloimmunization and refractoriness to random-donor platelet transfusions

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

Evidence-based recommendations for the use of WBC-reduced cellular blood components

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

Lowering the prophylactic platelet transfusion threshold: a prospective analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

Consensus Conference on Platelet Transfusion, Royal College of Physicians of Edinburgh, 27-28 November 1997. Synopsis of background papers.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

Prophylactic Platelet Transfusions in Children with Acute Leukemia: A Dose Response Study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

Thrombopoietin therapy increases platelet yields in healthy platelet donors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

Platelet associated IgG, platelet survival, and platelet sequestration in thrombocytopenic states

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

Mathematical modeling of platelet survival with implications for optimal transfusion practice in the chronically platelet transfusion-dependent patient

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

Urgent treatment of idiopathic thrombocytopenic purpura with single-dose gammaglobulin infusion followed by platelet transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

Measurement of platelet life-span in normal subjects and patients with myeloproliferative disease with indium oxine labelled platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

Reduced platelet survival following chemotherapy with vinblastine, bleomycin and cis-platinum for testicular teratoma

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

Economic consequences of alterations in platelet transfusion dose: analysis of a prospective, randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

Clinical recommendations using levels of evidence for antithrombotic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900018-X

7 January 2021

10.1016/S0887-7963(03)00018-X

Identifiers

DOI

1 reference

26 July 2017

1 reference

PubMed ID

12881779